GB202114315D0 - Pharmaceutical compound - Google Patents

Pharmaceutical compound

Info

Publication number
GB202114315D0
GB202114315D0 GBGB2114315.1A GB202114315A GB202114315D0 GB 202114315 D0 GB202114315 D0 GB 202114315D0 GB 202114315 A GB202114315 A GB 202114315A GB 202114315 D0 GB202114315 D0 GB 202114315D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compound
pharmaceutical
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2114315.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duke Street Bio Ltd
Original Assignee
Duke Street Bio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duke Street Bio Ltd filed Critical Duke Street Bio Ltd
Priority to GBGB2114315.1A priority Critical patent/GB202114315D0/en
Publication of GB202114315D0 publication Critical patent/GB202114315D0/en
Priority to JP2023560988A priority patent/JP2024514539A/en
Priority to BR112023019511A priority patent/BR112023019511A2/en
Priority to KR1020237037393A priority patent/KR20230171440A/en
Priority to CN202280039451.9A priority patent/CN117460723A/en
Priority to EP22719875.1A priority patent/EP4313300A1/en
Priority to IL305956A priority patent/IL305956A/en
Priority to PCT/EP2022/058490 priority patent/WO2022207752A1/en
Priority to CA3211149A priority patent/CA3211149A1/en
Priority to MX2023011378A priority patent/MX2023011378A/en
Priority to AU2022249724A priority patent/AU2022249724A1/en
Ceased legal-status Critical Current

Links

GBGB2114315.1A 2021-03-31 2021-10-06 Pharmaceutical compound Ceased GB202114315D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB2114315.1A GB202114315D0 (en) 2021-10-06 2021-10-06 Pharmaceutical compound
AU2022249724A AU2022249724A1 (en) 2021-03-31 2022-03-30 Pharmaceutical compound
CN202280039451.9A CN117460723A (en) 2021-03-31 2022-03-30 Pharmaceutical compounds
BR112023019511A BR112023019511A2 (en) 2021-03-31 2022-03-30 PARP7 INHIBITOR COMPOUND, COMPOUND, PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL KIT FOR THE TREATMENT OF A CANCER, METHOD OF TREATMENT OF A DISEASE AND/OR A CONDITION AND/OR A DISORDER, AND, METHOD OF SYNTHESIS OF A COMPOUND
KR1020237037393A KR20230171440A (en) 2021-03-31 2022-03-30 pharmaceutical compound
JP2023560988A JP2024514539A (en) 2021-03-31 2022-03-30 pharmaceutical compounds
EP22719875.1A EP4313300A1 (en) 2021-03-31 2022-03-30 Pharmaceutical compound
IL305956A IL305956A (en) 2021-03-31 2022-03-30 Pharmaceutical compound
PCT/EP2022/058490 WO2022207752A1 (en) 2021-03-31 2022-03-30 Pharmaceutical compound
CA3211149A CA3211149A1 (en) 2021-03-31 2022-03-30 Pharmaceutical compound
MX2023011378A MX2023011378A (en) 2021-03-31 2022-03-30 Pharmaceutical compound.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2114315.1A GB202114315D0 (en) 2021-10-06 2021-10-06 Pharmaceutical compound

Publications (1)

Publication Number Publication Date
GB202114315D0 true GB202114315D0 (en) 2021-11-17

Family

ID=78497732

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2114315.1A Ceased GB202114315D0 (en) 2021-03-31 2021-10-06 Pharmaceutical compound

Country Status (2)

Country Link
CN (1) CN117460723A (en)
GB (1) GB202114315D0 (en)

Also Published As

Publication number Publication date
CN117460723A (en) 2024-01-26

Similar Documents

Publication Publication Date Title
GB201911928D0 (en) Pharmaceutical compounds
GB202019241D0 (en) Pharmaceutical composition
GB202020191D0 (en) Pharmaceutical compounds
GB201911944D0 (en) Pharmaceutical compounds
GB201914910D0 (en) Pharmaceutical compounds
IL289619A (en) Pharmaceutical composition comprising a tetrahydropyrazolopyrimidinone compound
IL291570A (en) Pharmaceutical compounds
GB202010409D0 (en) Pharmaceutical compounds
GB202111193D0 (en) Pharmaceutical compounds
GB202200753D0 (en) Pharmaceutical compounds
GB202010408D0 (en) Pharmaceutical compounds
GB201915932D0 (en) Pharmaceutical compounds
GB201915273D0 (en) Pharmaceutical compounds
GB202114315D0 (en) Pharmaceutical compound
GB202104664D0 (en) Pharmaceutical compound
GB202117969D0 (en) Pharmaceutical compounds
GB202217888D0 (en) Pharmaceutical compound
GB202213819D0 (en) Pharmaceutical compound
GB202212967D0 (en) Pharmaceutical compound
GB202104097D0 (en) Pharmaceutical compounds
GB202102602D0 (en) Pharmaceutical compounds
GB202202070D0 (en) Pharmaceutical compound
GB202007163D0 (en) Pharmaceutical compounds
GB202003646D0 (en) Pharmaceutical compounds
GB202002144D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)